Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial

OBJECTIVES: To determine if commercially available mouthwash with β-cyclodextrin and citrox (bioflavonoids) (CDCM) could decrease the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) salivary viral load. METHODS: In this randomized controlled trial, severe acute respiratory syndrome coro...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrouel, Florence, Valette, Martine, Gadea, Emilie, Esparcieux, Aurélie, Illes, Gabriela, Langlois, Marie Elodie, Perrier, Hervé, Dussart, Claude, Tramini, Paul, Ribaud, Mélina, Bouscambert-Duchamp, Maude, Bourgeois, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142805/
https://www.ncbi.nlm.nih.gov/pubmed/34044151
http://dx.doi.org/10.1016/j.cmi.2021.05.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142805/
https://www.ncbi.nlm.nih.gov/pubmed/34044151
http://dx.doi.org/10.1016/j.cmi.2021.05.028

Ejemplares similares